New York Bill Would Create State-Sponsored Psychedelics Research Institute

A New York lawmaker introduced a bill on Tuesday that would require the state to establish an institute to research the therapeutic potential of psychedelics.

The legislation, sponsored by Assemblywoman Linda Rosenthal (D), would create a state-sanctioned research institute to explore the therapeutic potential of certain psychedelics and also require regulators to issue recommendations on the medical value of such substances in the treatment of conditions such as depression and post-traumatic stress disorder (PTSD).

“There is growing evidence to suggest that psychedelics, including psilocybin, can be a useful tool in treating symptoms of depression, anxiety, post-traumatic stress disorder and to help individuals recover from a substance use disorder,” a memo from Rosenthal about the the bill states. “Psychedelics provide a host of benefits without the same risk of overdose or dependency that other medications may provide.”

“This bill would provide New York State the opportunity to research the use of psychedelics and the many benefits they can provide,” it continues.
Read More